Clinical Trial

TBE Zone 2 PMS in Japan

Name: TBE Zone 2 PMS in Japan — clinical trial record (NCT07049913)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-06-25; most recent amendment 2026-02-04.

Status change: Not Yet Recruiting → Recruiting 2025-12-10

Trial Details

NCT Number	NCT07049913
Lead Sponsor	W.L.Gore & Associates Collaborators: CMIC Co, Ltd. Japan
Conditions	Aneurysm Thoracic, Dissection of Aorta, Thoracic, Trauma
Enrollment	200 participants
Start Date	2025-12-15
Primary Completion	2034-02 (estimated)
Study Completion	2034-02 (estimated)
Updated on ClinicalTrials.gov	2026-02-05